Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003596002 | SCV004293053 | pathogenic | Primary pulmonary hypertension | 2023-11-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn764Lysfs*49) in the BMPR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BMPR2 are known to be pathogenic (PMID: 16429395). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with pulmonary hypertension (PMID: 11115378). This variant is also known as 2292insA (N764fs). ClinVar contains an entry for this variant (Variation ID: 425977). For these reasons, this variant has been classified as Pathogenic. |
Rare Disease Genomics Group, |
RCV000488643 | SCV000576279 | pathogenic | Pulmonary hypertension, primary, 1 | no assertion criteria provided | literature only |